Sydney's Global Surgical Innovations wins $50K NSW grant for resorbable graft
What's the deal? Global Surgical InnovationsDealroom has a profile for this one. Try Dealroom → has received a $50,000 grant from the NSW Government's MVP Ventures Program to advance its regenerative surgical graft toward market. The Burwood-based company is one of several Sydney startups backed in the program's final 2025–26 round.
What's the endgame? The company is developing a regenerative, resorbable graft material designed to replace the harvesting of cartilage in nasal reconstructive surgery. The graft enables natural healing before dissolving, leaving no footprint in the body.
"Why harvest tissues when surgeons can use a consistent regenerative graft off-the-shelf?" said Dr Christella Mylordi, director and co-founder. The grant, she added, will "support the commercialisation of NSW-developed medical technology."
Who else won? The same round awarded $73,500 to UndaTechDealroom has a profile for this one. Try Dealroom →, founded in 2023 by former Royal Australian Navy sailor Emily Pyke. It is developing a fire-resistant undershirt for women working in defence, emergency services, construction, and mining.
Why now? The grants cap a program that has distributed about $3 million across three rounds in 2025–26, with awards generally capped at $50,000 or $75,000. Grants target the gap between prototype and commercialisation.
"Small businesses are the backbone of the NSW economy," said Minister for Small Business Janelle Saffin, "but bridging that critical funding gap between an innovative concept and commercial success is incredibly challenging."
The signal: NSW is leaning into product-development support for niche medical and protective-equipment firms, backed by a separate $20 million Emerging Technologies Commercialisation Fund. The money helps early products reach testing — though it alone does not prove either is near commercial scale.
Read more: cityhub.com.au
Image credit: Generated with Gemini
